Indexado en

Licencia y uso

Citaciones

Cited 1 times in

Altmetrics

Grant support

This study has been funded by Instituto de Salud Carlos III (ISCIII) through the project PI18/00393 and co-funded by the European Union. The ICA-Research Group has received unrestricted funding from Novartis and Orion Pharma. We appreciate the high pro-fessionalism of Alicia Diaz in the data management of the EAHFE Registry. The design of the study, patient inclusion, data analysis, discussion and final conclusions were exclusively carried out by the authors with no participation of the granters

Análisis de autorías institucional

Compartir

Relationship between clinical congestion and worsening renal function after intravenous initiation of furosemide in patients with acute heart failure

Publicado en:Internal And Emergency Medicine. 20 (5): 1553-1564 - 2025-08-01 20(5), DOI: 10.1007/s11739-024-03796-0

Autores: Espinosa B; Llauger L; Gil V; Escoda R; Jacob J; Aguirre A; Mojarro EM; Tost J; Alquézar-Arbé A; López-Grima ML; Millán J; Massó M; Cuquerella GS; Pagán F; Núñez J; Dauw J; Müllens W; Llorens P; Miró Ò

Afiliaciones

Resumen

To investigate if worsening renal function (WRF) appearing in some patients with acute heart failure (AHF) after intravenous furosemide initiation is influenced by severity of congestion. We conducted a retrospective secondary analysis of consecutive patients diagnosed with AHF and prospectively included in 10 Spanish emergency departments (EDs) for whom serum creatinine at ED arrival and after 2-7 days of intravenous furosemide initiation were available. Congestion was clinically evaluated by identification of 7 signs/symptoms and by chest X-ray. The outcome was WRF, defined as a delta-creatinine >= 0.3 mg/dL. Risk of WRF according to congestion was estimated in models adjusted by patient baseline characteristics and vitals at ED arrival, and interaction was also investigated. We included 3027 patients (median age 82 years, 56% women), and 657 (21.7%) presented WRF after intravenous furosemide initiation. When signs/symptoms were individually considered, only lower limbs edema was associated with decreased risk of WRF (20.1% vs. 24.8%; OR = 0.76, 95%CI = 0.64-0.91). After adjustment, lower limbs edema persisted inversely associated with WRF (aOR = 0.78, 95%CI = 0.65-0.94), with significant lower risk for patients 80 years), dementia, heart valve disease and NYHA class III-IV were associated with higher mortality. Intravenous furosemide initiation in patients with AHF without lower limbs edema must be cautious, as they are at increasing risk of developing WRF during the next following days, which in turn is associated with a higher 1-year mortality.

Palabras clave